As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...
U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective ...
U.S. regulators are reexamining infant RSV antibody treatments as safety questions surface, prompting new FDA scrutiny of ...
FDA officials are newly scrutinizing several approved therapies to treat RSV in babies despite the fact that these shots were shown to be safe in clinical trials ...
A committee that advises the Centers for Disease Control and Prevention on vaccines voted Thursday to recommend the use of a new preventative therapy for RSV in babies, Merck’s Enflonsia. The ...
(NewsNation) — Health and Human Services Secretary Robert F. Kennedy Jr.’s vaccine committee on Thursday voted to recommend a shot that protects babies against RSV, reports said. The shot, called ...
6don MSNOpinion
FDA launches safety review of two RSV drugs for infants as Kennedy scrutinizes immunizations
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...
In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...
Advisers endorse Merck RSV antibody The advisers also voted 5-2 on Thursday to recommend the use of a new shot that can protect babies from respiratory syncytial virus, adding an additional tool ...
The agency also is reviewing safety of immunizations for RSV, according to manufacturers of the therapies who have been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback